首页> 外文OA文献 >Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

【2h】

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

机译：接受以硼替佐米为基础的诱导方案（包括分阶段方法，PAD或VTD）的符合移植资格的中国骨髓瘤患者的治疗结果和预后因素分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chor Chim; Albert Kwok Lie; Eric Yuk Chan; Herman Sung Liu; Ching Lau; Sze Yip; Joycelyn Sim; Thomas Wan; Edmond Ma; Raymond Liang; Eric Tse; Yok-Lam Kwong; null null;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD [J] . Chor Sang Chim, Albert Kwok Wai Lie, Eric Yuk Tat Chan, Journal of Hematology and Oncology . 2012,第S1期

机译：接受以硼替佐米为基础的诱导方案（包括分阶段方法，PAD或VTD）的符合移植资格的中国骨髓瘤患者的治疗结果和预后因素分析
2. LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens [J] . Chim Chor Sang, Sim Joycelyn, Tam Sidney, European Journal of Haematology . 2015,第4期

机译：LDH是接受以硼替佐米为基础的诱导方案的适合移植的骨髓瘤患者的独立于ISS的不良预后因素
3. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens [J] . Qin Xiao-Ying, Lu Jin, Li Guo-Xuan, Annals of hematology . 2018,第3期

机译：CTLA-4多态性与接受基于Bortezomib的方案的多个骨髓瘤患者的治疗结果有关
4. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
5. Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach PAD or VTD [O] . Chor Sang Chim, Albert Kwok Wai Lie, Eric Yuk Tat Chan, 2012

机译：接受以硼替佐米为基础的诱导方案（包括分阶段方法PAD或VTD）的符合移植资格的中国骨髓瘤患者的治疗结果和预后因素分析
6. Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD [O] . Chim Chor, Lie Albert Kwok, Chan Eric Yuk, 2012

机译：接受硼替佐米诱导方案的移植患者中国骨髓瘤患者的治疗结果和预后因素分析，包括分期进近，paD或VTD

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

著录项

引文网络

相似文献

相关主题

期刊订阅